Description du poste
**PhD Position (Marie Skłodowska-Curie Doctoral Network) on 'Revealing peroxisome metabolism and dynamics during influenza virus infection'**
---------------------------------------------------------------------------------------------------------------------------------------------
*(ref. BAP-2026-654)*
*Laatst aangepast: 12/11/26*
KU Leuven (University of Leuven), founded in 1425, is one of Europe's oldest and most prestigious universities. Ranked among the world's leading research universities and consistently recognized as one of Europe's most innovative institutions, KU Leuven provides an outstanding environment for doctoral training and scientific discovery.
The PhD research will be conducted at the Rega Institute for Medical Research, a multidisciplinary and internationally renowned research center with a strong track record in virology, microbiology, immunology, and the development of innovative therapies for infectious diseases.
The doctoral candidate will join the Molecular, Structural and Translational Virology (MSTV) group. MSTV develops novel antiviral and host-directed therapeutic strategies through a detailed understanding of viral replication mechanisms and virus-host interactions. Within MSTV, the team led by Prof. Lieve Naesens studies influenza viruses and coronaviruses, combining expertise in molecular virology, cell biology, antiviral drug discovery, and advanced infection models. The team has discovered multiple first-in-class inhibitors targeting viral entry and genome replication and investigates host pathways that can be exploited to broadly combat respiratory virus infections and associated lung disease.
As part of a Marie Skłodowska-Curie Doctoral Network, the successful candidate will work in a highly international and interdisciplinary environment, benefiting from collaborative research projects, network-wide training activities, and secondments at leading European academic and industrial partner institutions.
##### **Project**
Viral infections remain a major threat to global health, as illustrated by recurring influenza epidemics and the risk of future pandemics. New antiviral strategies are urgently needed, particularly approaches that target host pathways rather than viral components, thereby offering broader and more durable protection against diverse viruses. Peroxisomes are emerging as key cellular organelles in this context because they play critical roles in lipid metabolism, innate immunity, and viral replication. Despite their therapeutic potential, progress in this field is hampered by a shortage of researchers trained at the interface of virology and peroxisome biology. The **VirION** Doctoral Network addresses this challenge by training 15 Doctoral Candidates in an interdisciplinary and international research programme that integrates virology, organelle biology, systems biology, and innovation.
Within the VirION network, the doctoral candidate at the Rega Institute will investigate how i